Literature DB >> 12144530

Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor.

Sha Tian1, Hetti Poukka, Jorma J Palvimo, Olli A Jänne.   

Abstract

Small ubiquitin-related modifier-1 (SUMO-1) is covalently attached to many cellular targets to regulate protein-protein and protein-DNA interactions, as well as localization and stability of the target protein. The SUMO-1-conjugating E2 enzyme Ubc9 is known to interact with the glucocorticoid receptor (GR), a ligand-dependent transcription factor. In the present study, we show that GR is post-translationally modified by SUMO-1 (sumoylated) in a ligand-enhanced fashion. We identify experimentally three consensus SUMO attachment sites, two in the N-terminal transactivation region and one in the ligand-binding domain of GR. The two N-terminal sites are the major acceptor sites for SUMO-1 attachment. Mutation of these sites enhances transcriptional activity of GR on minimal promoters, but has no clear effect on the more complex mouse mammary tumour virus promoter. Thus SUMO-1 modification of GR influences receptor function in a promoter context-dependent fashion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12144530      PMCID: PMC1222934          DOI: 10.1042/BJ20021085

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

1.  Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1.

Authors:  M Gostissa; A Hengstermann; V Fogal; P Sandy; S E Schwarz; M Scheffner; G Del Sal
Journal:  EMBO J       Date:  1999-11-15       Impact factor: 11.598

2.  SUMO-1 modification activates the transcriptional response of p53.

Authors:  M S Rodriguez; J M Desterro; S Lain; C A Midgley; D P Lane; R T Hay
Journal:  EMBO J       Date:  1999-11-15       Impact factor: 11.598

Review 3.  The coregulator exchange in transcriptional functions of nuclear receptors.

Authors:  C K Glass; M G Rosenfeld
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

4.  A new 30-kDa ubiquitin-related SUMO-1 hydrolase from bovine brain.

Authors:  T Suzuki; A Ichiyama; H Saitoh; T Kawakami; M Omata; C H Chung; M Kimura; N Shimbara; K Tanaka
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

5.  Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome.

Authors:  C A Lange; T Shen; K B Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

6.  Ubc9 is a novel modulator of the induction properties of glucocorticoid receptors.

Authors:  Sunil Kaul; John A Blackford; Sehyung Cho; S Stoney Simons
Journal:  J Biol Chem       Date:  2002-01-25       Impact factor: 5.157

7.  Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity.

Authors:  Juraj Bies; Ján Markus; Linda Wolff
Journal:  J Biol Chem       Date:  2002-01-04       Impact factor: 5.157

8.  Cell cycle-regulated attachment of the ubiquitin-related protein SUMO to the yeast septins.

Authors:  E S Johnson; G Blobel
Journal:  J Cell Biol       Date:  1999-11-29       Impact factor: 10.539

9.  SUMO-1 targets RanGAP1 to kinetochores and mitotic spindles.

Authors:  Jomon Joseph; Shyh-Han Tan; Tatiana S Karpova; James G McNally; Mary Dasso
Journal:  J Cell Biol       Date:  2002-02-18       Impact factor: 10.539

10.  PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1.

Authors:  A M Ishov; A G Sotnikov; D Negorev; O V Vladimirova; N Neff; T Kamitani; E T Yeh; J F Strauss; G G Maul
Journal:  J Cell Biol       Date:  1999-10-18       Impact factor: 10.539

View more
  53 in total

Review 1.  Modification with SUMO. A role in transcriptional regulation.

Authors:  Alexis Verger; José Perdomo; Merlin Crossley
Journal:  EMBO Rep       Date:  2003-02       Impact factor: 8.807

2.  Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy.

Authors:  Sam Holmstrom; Mary E Van Antwerp; Jorge A Iñiguez-Lluhi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-08       Impact factor: 11.205

3.  SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression.

Authors:  Gergana Dobreva; Julia Dambacher; Rudolf Grosschedl
Journal:  Genes Dev       Date:  2003-12-15       Impact factor: 11.361

4.  PPARs and lipid ligands in inflammation and metabolism.

Authors:  Gregory S Harmon; Michael T Lam; Christopher K Glass
Journal:  Chem Rev       Date:  2011-10-12       Impact factor: 60.622

Review 5.  SUMO wrestling with type 1 diabetes.

Authors:  Manyu Li; Dehuang Guo; Carlos M Isales; Decio L Eizirik; Mark Atkinson; Jin-Xiong She; Cong-Yi Wang
Journal:  J Mol Med (Berl)       Date:  2005-04-02       Impact factor: 4.599

6.  A small conserved surface in SUMO is the critical structural determinant of its transcriptional inhibitory properties.

Authors:  Sergey Chupreta; Sam Holmstrom; Lalitha Subramanian; Jorge A Iñiguez-Lluhí
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

7.  Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner.

Authors:  Hideki Murakami; Heinz Arnheiter
Journal:  Pigment Cell Res       Date:  2005-08

8.  SUMO-targeted ubiquitin ligases in genome stability.

Authors:  John Prudden; Stephanie Pebernard; Grazia Raffa; Daniela A Slavin; J Jefferson P Perry; John A Tainer; Clare H McGowan; Michael N Boddy
Journal:  EMBO J       Date:  2007-08-30       Impact factor: 11.598

9.  Negative modulation of androgen receptor transcriptional activity by Daxx.

Authors:  Ding-Yen Lin; Hsin-I Fang; Ai-Hong Ma; Yen-Sung Huang; Yeong-Shiau Pu; Guido Jenster; Hsing-Jien Kung; Hsiu-Ming Shih
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

10.  SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX.

Authors:  Sam R Holmstrom; Sergey Chupreta; Alex Yick-Lun So; Jorge A Iñiguez-Lluhí
Journal:  Mol Endocrinol       Date:  2008-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.